Veinly is building the UK's leading clinician-owned vein care group. We acquire circa 60% of your clinic for a total of 3.5x the profits attaching to that stake — 2x in cash at completion and a further 1.5x twelve months later — while you keep 40%, keep clinical control, keep your income, and take a second payment when the group is sold.
†Payable 12 months after completion, subject to maintained EBITDA. The 2x and 1.5x multiples apply to the 60% share of EBITDA acquired (£180,000 in this illustration). *Illustrated at a 9x group multiple on £420,000 of grown clinic profit. Plus your clinical income and 40% of profits en route. Figures are illustrative only — not an offer or forecast; every clinic is valued on its own numbers.
Private-equity-backed chains are buying and building vein clinics across the UK at pace, and international groups have entered the market. Independents face a widening gap.
Chains compete on Google advertising budgets, call-centre conversion and consultant recruitment. Marketing inflation hits a single-site clinic hardest — however excellent it is clinically.
CQC compliance, indemnity, procurement and admin all land on one owner's desk. A group carries these once, centrally — an independent carries them alone, every year.
When a solo owner retires, the business value often retires too. Consultant vascular surgeons are scarce, and few will buy a single-handed private clinic. Un-partnered, excellent clinics become un-sellable.
The sell-majority-keep-a-stake model — long established in dentistry, veterinary and optometry — applied to vein care, and built so clinicians keep meaningful equity in the clinics they founded.
We acquire circa 60% of your clinic for a total of 3.5x the normalised EBITDA attaching to that stake — 2x paid in cash at completion, and a further 1.5x twelve months later, subject to maintained EBITDA. You take a meaningful capital sum off the table now — de-risking years of work.
Liquidity todayYou remain a genuine part-owner of the unit you built — not a small fraction of someone else's group — and continue to receive 40% of its profits. You practise under a market-rate clinical agreement, and clinical decisions stay with clinicians.
Autonomy in practiceWhen the group is sold — targeted within three to four years — your retained 40% is bought at the same multiple the group achieves. Because groups sell for materially higher multiples than single clinics, this second payment is typically larger than the first.
Group-exit upsideEvery clinic is valued on its own normalised profits. Use the illustration below to see the shape of the deal at your clinic's scale.
Drag to your clinic's approximate annual profit (EBITDA)
Illustrative only — not an offer, valuation or forecast. Assumes 60% acquired for 3.5x the normalised EBITDA attaching to that stake (60% of clinic EBITDA) — 2x at completion plus 1.5x at 12 months (subject to maintained EBITDA) — profit growth of 40% with group support, and a group exit at 9x. Excludes your clinical income and your 40% share of profits en route. Every clinic is valued on its own numbers; recipients should take independent professional advice.
| Stay independent | Join Veinly | |
|---|---|---|
| Clinic profit (EBITDA) | £300,000 | £300,000 growing with group support |
| Value today | £1.2m (4x) — if a buyer can be found | £630k for 60% — £360k at completion + £270k at 12 months† |
| Your retained stake | — | 40%, sold at group exit: ~£1.5m* |
| Marketing, CQC, admin | Carried alone | Carried by the group platform |
| Succession | Unsolved | Solved — group surgical cover |
| Total over ~4 years | £1.2m (once, eventually) | ~£2.1m + clinical income + 40% of profits en route |
†The 2x and 1.5x multiples apply to the 60% share of EBITDA acquired (£180,000 here); the 1.5x payment is made 12 months after completion, subject to maintained EBITDA. *Illustrated at 9x on £420,000 of grown profit. Figures are illustrative, not an offer or forecast; every clinic is valued on its own numbers.
Veinly provides the group infrastructure built for our dental group, Implantly — so you can focus on medicine, not administration.
Group-scale Google advertising, a national consumer brand and patient acquisition that no single clinic can match — plus cross-referral from the group's existing patient base.
Central booking, triage and enquiry handling, seven days a week — converting more of the demand your reputation and our marketing generate.
Registration, governance, audit and inspection-readiness run centrally by a team that does it every day — lifting the regulatory burden off your shoulders.
Devices, consumables and indemnity negotiated at group scale — savings that flow straight into the clinic profits you still share 40% of.
Payroll, bookkeeping, recruitment and HR handled centrally — the back office already serving the Implantly group, extended to your clinic.
A group surgical rota provides cover for leave, illness and — when you choose — retirement. The succession problem that traps single-handed clinics is solved at group level.
Structures of this kind are long established across UK healthcare. Founders banked value early and shared in the group premium later.
A chain buys 100%, rebrands you, and keeps the platform upside. Veinly keeps you on the right side of the multiple arbitrage — instead of handing it away.
No obligation at any stage. Full confidentiality throughout, and your team, brand and premises stay in place.
A confidential, no-obligation call with Graham Byrne to understand your clinic, your plans and whether the model fits. Nothing is required of you but half an hour.
We exchange a mutual NDA so numbers can be shared safely in both directions before anything else happens.
Based on your normalised profits, we give you a written indication of the 2x completion payment, the 1.5x twelve-month payment and the shape of your retained 40% — so you can judge the deal on real numbers.
Focused, proportionate due diligence and legal documentation. You should take independent professional advice throughout — we'll expect and encourage it.
You receive 2x the acquired share of EBITDA in cash, with a further 1.5x payable 12 months later. You keep 40% and your clinical income, and the group platform switches on behind your clinic. Group exit is targeted within three to four years.
No obligation, full confidentiality. An initial conversation takes half an hour — and a confidential indication of value for your clinic can usually follow within two weeks under NDA.
Prefer to skip the form? Contact Graham Byrne directly — every enquiry is handled personally and in confidence.
Tell us a little about you and your clinic — we'll come back within one working day.